514
Views
6
CrossRef citations to date
0
Altmetric
Comprehensive review

Cardiometabolic impacts of saturated fatty acids: are they all comparable?

, , ORCID Icon, & ORCID Icon
Pages 1-14 | Received 23 Feb 2021, Accepted 04 Jun 2021, Published online: 06 Jul 2021

References

  • Aguilar EC, Leonel AJ, Teixeira LG, Silva AR, Silva JF, Pelaez JMN, Capettini LSA, Lemos VS, Santos RAS, Alvarez-Leite JI, et al. 2014. Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFκB activation. Nutr Metab Cardiovasc Dis. 24(6):606–613.
  • Akpa MM, Point F, Sawadogo S, Radenne A, Mounier C. 2010. Inhibition of insulin and T3-induced fatty acid synthase by hexanoate. Lipids. 45(11):997–1009.
  • Alhabeeb H, AlFaiz A, Kutbi E, AlShahrani D, Alsuhail A, AlRajhi S, Alotaibi N, Alotaibi K, AlAmri S, Alghamdi S, et al. 2021. Gut hormones in health and obesity: the upcoming role of short chain fatty acids. Nutrients. 13(2):481.
  • Alhazmi A, Stojanovski E, Garg ML, McEvoy M. 2014. Fasting whole blood fatty acid profile and risk of type 2 diabetes in adults: a nested case control study. PLOS One. 9(5):e97001.
  • Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. 2010. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta. 1801(11):1175–1183.
  • Almaguel FG, Liu J-W, Pacheco FJ, Casiano CA, De Leon M. 2009. Activation and reversal of lipotoxicity in PC12 and rat cortical cells following exposure to palmitic acid. J Neurosci Res. 87(5):1207–1218.
  • Anderson JW, Baird P, Davis RH, Ferreri S, Knudtson M, Koraym A, Waters V, Williams CL. 2009. Health benefits of dietary fiber. Nutr Rev. 67(4):188–205.
  • Aro A, Jauhiainen M, Partanen R, Salminen I, Mutanen M. 1997. Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. Am J Clin Nutr. 65(5):1419–1426.
  • Bach AC, Babayan VK. 1982. Medium-chain triglycerides: an update. Am J Clin Nutr. 36(5):950–962.
  • Baer DJ, Judd JT, Clevidence BA, Tracy RP. 2004. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr. 79(6):969–973.
  • Batal M, Steinhouse L, Delisle H. 2018. The nutrition transition and the double burden of malnutrition. Med Sante Trop. 28(4):345–350.
  • Batista Filho M, Batista LV. 2010. Transição alimentar/nutricional ou mutação antropológica? Ciência e Cultura. 62:26–30.
  • Belakavadi M, Prabhakar BT, Salimath BP. 2007. Purification and characterization of butyrate-induced protein phosphatase involved in apoptosis of Ehrlich ascites tumor cells. Biochim Biophys Acta. 1770(1):39–47.
  • Berlanga A, Guiu-Jurado E, Porras JA, Auguet T. 2014. Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol. 7:221–239.
  • Blazquez C, Galve-Roperh I, Guzmán M. 2000. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. Faseb J. 14(14):2315–2322.
  • Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH. 2004. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol. 36(7):1187–1205.
  • Braverman NE, Moser AB. 2012. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta. 9(52):22.
  • Brereton MF, Vergari E, Zhang Q, Clark A. 2015. Alpha-, delta- and PP-cells: are they the architectural cornerstones of islet structure and co-ordination? J Histochem Cytochem. 63(8):575–591.
  • Byrne CS, Chambers ES, Morrison DJ, Frost G. 2015. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes (Lond)). 39(9):1331–1338.
  • Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SEK, MacDougall K, Preston T, Tedford C, Finlayson GS, et al. 2015. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 64(11):1744–1754.
  • Chen J, Ghazawi FM, Bakkar W, Li Q. 2006. Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B. Mol Cancer. 5(1):71.
  • Chen WJ, Anderson JW, Jennings D. 1984. Propionate may mediate the hypocholesterolemic effects of certain soluble plant fibers in cholesterol-fed rats. Proc Soc Exp Biol Med. 175(2):215–218.
  • Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, et al. 2014. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 160(6):398–406.
  • Chu KY, Lin Y, Hendel A, Kulpa JE, Brownsey RW, Johnson JD. 2010. ATP-citrate lyase reduction mediates palmitate-induced apoptosis in pancreatic beta cells. J Biol Chem. 285(42):32606–32615.
  • Consitt LA, Bell JA, Houmard JA. 2009. Intramuscular lipid metabolism, insulin action, and obesity. IUBMB Life. 61(1):47–55.
  • Cook SI, Sellin JH. 1998. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther. 12(6):499–507.
  • Covington DK, Briscoe CA, Brown AJ, Jayawickreme CK. 2006. The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing. Biochem Soc Trans. 34(Pt 5):770–773.
  • Cummings JH. 1981. Short chain fatty acids in the human colon. Gut. 22(9):763–779.
  • Cusi K. 2009. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis. 13(4):545–563.
  • De Silva A, Salem V, Long CJ, Makwana A, Newbould RD, Rabiner EA, Ghatei MA, Bloom SR, Matthews PM, Beaver JD, et al. 2011. The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab. 14(5):700–706.
  • Demigné C, Morand C, Levrat MA, Besson C, Moundras C, Rémésy C. 1995. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br J Nutr. 74(2):209–219.
  • DiCostanzo A, Williams JE, Keisler DH. 1999. Effects of short- or long-term infusions of acetate or propionate on luteinizing hormone, insulin, and metabolite concentrations in beef heifers. J Anim Sci. 77(11):3050–3056.
  • Drosatos K, Bharadwaj KG, Lymperopoulos A, Ikeda S, Khan R, Hu Y, Agarwal R, Yu S, Jiang H, Steinberg SF, et al. 2011. Cardiomyocyte lipids impair β-adrenergic receptor function via PKC activation. Am J Physiol Endocrinol Metab. 300(3):E489–E499.
  • EFSA Panel on Dietetic Products, N. and Allergies. 2010. Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J. 8(3):1461.
  • Everard A, Cani PD. 2014. Gut microbiota and GLP-1. Rev Endocr Metab Disord. 15(3):189–196.
  • Eyres L, Eyres MF, Chisholm A, Brown RC. 2016. Coconut oil consumption and cardiovascular risk factors in humans. Nutr Rev. 74(4):267–280.
  • Fang X, Palanivel R, Cresser J, Schram K, Ganguly R, Thong FSL, Tuinei J, Xu A, Abel ED, Sweeney G, et al. 2010. An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. Am J Physiol Endocrinol Metab. 299(5):E721–E729.
  • Fattore E, Bosetti C, Brighenti F, Agostoni C, Fattore G. 2014. Palm oil and blood lipid-related markers of cardiovascular disease: a systematic review and meta-analysis of dietary intervention trials. Am J Clin Nutr. 99(6):1331–1350.
  • Fernandez-Real J-M, Broch M, Vendrell J, Ricart W. 2003. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care. 26(5):1362–1368.
  • Forouhi NG, Koulman A, Sharp SJ, Imamura F, Kröger J, Schulze MB, Crowe FL, Huerta JM, Guevara M, Beulens JWJ, et al. 2014. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2(10):810–818.
  • Fretts AM, Mozaffarian D, Siscovick DS, Djousse L, Heckbert SR, King IB, McKnight B, Sitlani C, Sacks FM, Song X, et al. 2014. Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study. J Am Heart Assoc. 3(3):e000889.
  • Galisteo M, Duarte J, Zarzuelo A. 2008. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem. 19(2):71–84.
  • Gallo S, Egeland G, Meltzer S, Legault L, Kubow S. 2010. Plasma fatty acids and desaturase activity are associated with circulating adiponectin in healthy adolescent girls. J Clin Endocrinol Metab. 95(5):2410–2417.
  • Garwolińska D, Namieśnik J, Kot-Wasik A, Hewelt-Belka W. 2018. Chemistry of human breast milk – a comprehensive review of the composition and role of milk metabolites in child development. J Agric Food Chem. 66(45):11881–11896
  • Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen J-L, Tian H, Li Y. 2008. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology. 149(9):4519–4526.
  • Goldberg IJ, Trent CM, Schulze PC. 2012. Lipid metabolism and toxicity in the heart. Cell Metab. 15(6):805–812.
  • Halatchev IG, Cone RD. 2005. Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice. Cell Metab. 1(3):159–168.
  • Harvey KA, Walker CL, Pavlina TM, Xu Z, Zaloga GP, Siddiqui RA. 2010. Long-chain saturated fatty acids induce pro-inflammatory responses and impact endothelial cell growth. Clin Nutr. 29(4):492–500.
  • Hashemi Z, Fouhse J, Im H, Chan C, Willing B. 2017. Dietary pea fiber supplementation improves glycemia and induces changes in the composition of gut microbiota, serum short chain fatty acid profile and expression of mucins in glucose intolerant rats. Nutrients. 9(11):1236.
  • Hong Y-H, Nishimura Y, Hishikawa D, Tsuzuki H, Miyahara H, Gotoh C, Choi K-C, Feng DD, Chen C, Lee H-G, et al. 2005. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology. 146(12):5092–5099.
  • Hooper LV, Midtvedt T, Gordon JI. 2002. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr. 22(1):283–307.
  • Hotamisligil GS. 2006. Inflammation and metabolic disorders. Nature. 444(7121):860–867.
  • Hunter JE, Zhang J, Kris-Etherton PM. 2010. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr. 91(1):46–63.
  • Iggman D, Risérus U. 2011. Role of different dietary saturated fatty acids for cardiometabolic risk. Clin Lipidol. 6(2):209–223.
  • Isaacs CE. 2005. Human milk inactivates pathogens individually, additively, and synergistically. J Nutr. 135(5):1286–1288.
  • Jenkins B, Aoun M, Feillet-Coudray C, Coudray C, Ronis M, Koulman A. 2018. The dietary total-fat content affects the in vivo circulating C15:0 and C17:0 fatty acid levels independently. Nutrients. 10(11):1646.
  • Jenkins B, West JA, Koulman A. 2015. A review of odd-chain fatty acid metabolism and the role of pentadecanoic acid (c15:0) and heptadecanoic acid (c17:0) in health and disease. Molecules. 20(2):2425–2444.
  • Jenkins DJ, Wolever TM, Jenkins A, Brighenti F, Vuksan V, Rao AV, Cunnane SC, Ocana A, Corey P, Vezina C, et al. 1991. Specific types of colonic fermentation may raise low-density-lipoprotein-cholesterol concentrations. Am J Clin Nutr. 54(1):141–147.
  • Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K-i, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, et al. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 116(6):1494–1505.
  • Kawamura N, Moser HW, Kishimoto Y. 1981. Very long chain fatty acid oxidation in rat liver. " Biochem Biophys Res Commun. 99(4):1216–1225.
  • Kelly FD, Sinclair AJ, Mann NJ, Turner AH, Abedin L, Li D. 2001. A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males. Eur J Clin Nutr. 55(2):88–96.
  • Kennedy A, Martinez K, Chuang C-C, LaPoint K, McIntosh M. 2009. Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J Nutr. 139(1):1–4.
  • Khaw K-T, Friesen MD, Riboli E, Luben R, Wareham N. 2012. Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLOS Med. 9(7):e1001255.
  • Kono H, Fujii H, Asakawa M, Masayuki Y, Matsuda M, Maki A, Matsumoto Y. 2003. Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin. Ann Surg. 237(2):246–255.
  • Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B, Weinehall L, Lindahl B. 2008. Fatty acid profile of the erythrocyte membrane preceding development of type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis. 18(7):503–510.
  • Kris-Etherton PM, Yu S. 1997. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr. 65(5 Suppl):1628S–1644S.
  • Lemaitre RN, Fretts AM, Sitlani CM, Biggs ML, Mukamal K, King IB, Song X, Djoussé L, Siscovick DS, McKnight B, et al. 2015. Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study. Am J Clin Nutr. 101(5):1047–1054.
  • Levrat MA, Favier ML, Moundras C, Rémésy C, Demigné C, Morand C. 1994. Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J Nutr. 124(4):531–538.
  • Libby P, Ridker PM, Maseri A. 2002. Inflammation and atherosclerosis. Circulation. 105(9):1135–1143.
  • Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, Southern PJ, Reilly CS, Peterson ML, Schultz-Darken N, Brunner KG, et al. 2009. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 458(7241):1034–1038.
  • Li H, Liu Y, Zhang X, Xu Q, Zhang Y, Xue C, Guo C. 2018. Medium-chain fatty acids decrease serum cholesterol via reduction of intestinal bile acid reabsorption in C57BL/6J mice. Nutr Metab. 15(1):37.
  • Li M, van Esch BCAM, Henricks PAJ, Garssen J, Folkerts G. 2018. Time and concentration dependent effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor α-induced endothelial activation. Front Pharmacol. 9:233.
  • Magnusdottir OK, Landberg R, Gunnarsdottir I, Cloetens L, Akesson B, Landin-Olsson M, Rosqvist F, Iggman D, Schwab U, Herzig K-H, et al. 2014. Plasma alkylresorcinols C17:0/C21:0 ratio, a biomarker of relative whole-grain rye intake, is associated to insulin sensitivity: a randomized study. Eur J Clin Nutr. 68(4):453–458.
  • Malik VS, Chiuve SE, Campos H, Rimm EB, Mozaffarian D, Hu FB, Sun Q. 2015. Circulating very-long-chain saturated fatty acids and incident coronary heart disease in US men and women. Circulation. 132(4):260–268.
  • Mansson HL. 2008. Fatty acids in bovine milk fat. Food Nutr Res. 52: 1821.
  • Marten B, Pfeuffer M, Schrezenmeir J. 2006. Medium-chain triglycerides. Int Dairy J. 16(11):1374–1382.
  • Martins AR, Nachbar RT, Gorjao R, Vinolo MA, Festuccia WT, Lambertucci RH, Cury-Boaventura MF, Silveira LR, Curi R, Hirabara SM, et al. 2012. Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function. Lipids Health Dis. 11:30–30.
  • Matsumori R, Miyazaki T, Shimada K, Kume A, Kitamura Y, Oshida K, Yanagisawa N, Kiyanagi T, Hiki M, Fukao K, et al. 2013. High levels of very long-chain saturated fatty acid in erythrocytes correlates with atherogenic lipoprotein profiles in subjects with metabolic syndrome. Diabetes Res Clin Pract. 99(1):12–18.
  • Mensink RP, Zock PL, Kester ADM, Katan MB. 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 77(5):1146–1155.
  • Micha R, Mozaffarian D. 2010. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids. 45(10):893–905.
  • Miller TA, LeBrasseur NK, Cote GM, Trucillo MP, Pimentel DR, Ido Y, Ruderman NB, Sawyer DB. 2005. Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes. Biochem Biophys Res Commun. 336(1):309–315.
  • Miyazaki T, Shimada K, Hiki M, Kume A, Kitamura Y, Oshida K, Yanagisawa N, Kiyanagi T, Matsumori R, Daida H, et al. 2014. High hexacosanoic acid levels are associated with coronary artery disease. Atherosclerosis. 233(2):429–433.
  • Moser AB, Kreiter N, Bezman L, Lu S-E, Raymond GV, Naidu S, Moser HW. 1999. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol. 45(1):100–110.
  • Mu YM, Yanase T, Nishi Y, Tanaka A, Saito M, Jin CH, Mukasa C, Okabe T, Nomura M, Goto K, et al. 2001. Saturated FFAs, palmitic acid and stearic acid, induce apoptosis in human granulosa cells. Endocrinology. 142(8):3590–3597.
  • Nicholls SJ, Lundman P, Harmer JA, Cutri B, Griffiths KA, Rye K-A, Barter PJ, Celermajer DS. 2006. Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. J Am Coll Cardiol. 48(4):715–720.
  • Nishina PM, Freedland RA. 1990. Effects of propionate on lipid biosynthesis in isolated rat hepatocytes. J Nutr. 120(7):668–673.
  • Ohira H, Fujioka Y, Katagiri C, Mamoto R, Aoyama-Ishikawa M, Amako K, Izumi Y, Nishiumi S, Yoshida M, Usami M, et al. 2013. Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages. J Atheroscler Thromb. 20(5):425–442.
  • Ohira H, Tsutsui W, Fujioka Y. 2017. Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis? J Atheroscler Thromb. 24(7):660–672.
  • Park M, Sweeney G. 2013. Direct effects of adipokines on the heart: focus on adiponectin. Heart Fail Rev. 18(5):631–644.
  • Park M, Youn BS, Zheng X-L, Wu D, Xu A, Sweeney G. 2011. Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis. PLOS One. 6(4):e19143.
  • Peters SG, Pomare EW, Fisher CA. 1992. Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. Gut. 33(9):1249–1252.
  • Pimentel GD, Lira FS, Rosa JC, Oliveira JL, Losinskas-Hachul AC, Souza GIH, das Graças T. do Carmo M, Santos RVT, de Mello MT, Tufik S, et al. 2012. Intake of trans fatty acids during gestation and lactation leads to hypothalamic inflammation via TLR4/NFkappaBp65 signaling in adult offspring. J Nutr Biochem. 23(3):265–271.
  • Pirola L, Ferraz JC. 2017. Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity. World J Biol Chem. 8(2):120–128.
  • Popkin BM, Adair LS, Ng SW. 2012. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 70(1):3–21.
  • Popkin BM, Gordon-Larsen P. 2004. The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes. 28(S3):S2–S9.
  • Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, Bandyopadhyay S, Jones KN, Kelly S, Shaner RL, et al. 2010. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 51(11):3299–3305.
  • Reilly SM, Lee CH. 2008. PPAR delta as a therapeutic target in metabolic disease. FEBS Lett. 582(1):26–31.
  • Riserus U, Marklund M. 2017. Milk fat biomarkers and cardiometabolic disease. Curr Opin Lipidol. 28(1):46–51.
  • Ruan J-S, Lin J-K, Kuo Y-Y, Chen Y-W, Chen P-C. 2018. Chronic palmitic acid-induced lipotoxicity correlates with defective trafficking of ATP sensitive potassium channels in pancreatic β cells. J Nutr Biochem. 59:37–48.
  • Samuel VT. 2011. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab. 22(2):60–65.
  • Sanders TA. 2009. Fat and fatty acid intake and metabolic effects in the human body. Ann Nutr Metab. 55(1–3):162–172.
  • Sanders FWB, Griffin JL. 2016. De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol Rev Camb Philos Soc. 91(2):452–468.
  • Seaton TB, Welle SL, Warenko MK, Campbell RG. 1986. Thermic effect of medium-chain and long-chain triglycerides in man. Am J Clin Nutr. 44(5):630–634.
  • Sengupta S, Muir JG, Gibson PR. 2006. Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol. 21(1 Pt 2):209–218.
  • Silva SMCSd, Mura JDAP. 2007. Tratado de Alimentação, Nutrição e Dietoterapia [Treated to feeding, nutrition and diet therapy]. 1st ed. São Paulo, Brazil: Roca.
  • Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Geary N. 2017. Ghrelin, CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB. Physiol Rev. 97(1):411–463.
  • Suganami T, Nishida J, Ogawa Y. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 25(10):2062–2068.
  • Thaler JP, Yi C-X, Schur EA, Guyenet SJ, Hwang BH, Dietrich MO, Zhao X, Sarruf DA, Izgur V, Maravilla KR, et al. 2012. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 122(1):153–162.
  • Thijssen MAMA, Hornstra G, Mensink RP. 2005. Stearic, oleic, and linoleic acids have comparable effects on markers of thrombotic tendency in healthy human subjects. J Nutr. 135(12):2805–2811.
  • Timper K, Bruning JC. 2017. Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity. Dis Model Mech. 10(6):679–689.
  • Topping DL, Clifton PM. 2001. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 81(3):1031–1064.
  • Traul KA, Driedger A, Ingle DL, Nakhasi D. 2000. Review of the toxicologic properties of medium-chain triglycerides. Food Chem Toxicol. 38(1):79–98.
  • Vieitez I, Irigaray B, Callejas N, González V, Gimenez S, Arechavaleta A, Grompone M, Gámbaro A. 2016. Composition of fatty acids and triglycerides in goat cheeses and study of the triglyceride composition of goat milk and cow milk blends. J Food Compos Anal. 48:95–101.
  • Vogt JA, Pencharz PB, Wolever TM. 2004. l-Rhamnose increases serum propionate in humans. Am J Clin Nutr. 80(1):89–94.
  • Wang B, Fu J, Li L, Gong D, Wen X, Yu P, Zeng Z. 2016. Medium-chain fatty acid reduces lipid accumulation by regulating expression of lipid-sensing genes in human liver cells with steatosis. Int J Food Sci Nutr. 67(3):288–297.
  • Waqar AB, Koike T, Yu Y, Inoue T, Aoki T, Liu E, Fan J. 2010. High-fat diet without excess calories induces metabolic disorders and enhances atherosclerosis in rabbits. Atherosclerosis. 213(1):148–155.
  • Watkins PA. 1997. Fatty acid activation. Prog Lipid Res. 36(1):55–83.
  • Wende AR, Abel ED. 2010. Lipotoxicity in the heart. Biochim Biophys Acta. 1801(3):311–319.
  • Wolever TMS, Josse RG, Leiter LA, Chiasson J-L. 1997. Time of day and glucose tolerance status affect serum short-chain fatty concentrations in humans. Metab Clin Exp. 46(7):805–811.
  • Wolever TM, Schrade KB, Vogt JA, Tsihlias EB, McBurney MI. 2002. Do colonic short-chain fatty acids contribute to the long-term adaptation of blood lipids in subjects with type 2 diabetes consuming a high-fiber diet? Am J Clin Nutr. 75(6):1023–1030.
  • Wong JMW, de Souza R, Kendall CWC, Emam A, Jenkins DJA. 2006. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 40(3):235–243.
  • Yamazaki Y, Kondo K, Maeba R, Nishimukai M, Nezu T, Hara H. 2014. Proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome. J Oleo Sci. 63(5):527–537.
  • Yang H, Li X. 2012. The role of fatty acid metabolism and lipotoxicity in pancreatic β-cell injury: identification of potential therapeutic targets. " Acta Pharmaceutica Sinica B. 2(4):396–402.
  • Young GP, Hu Y, Le Leu RK, Nyskohus L. 2005. Dietary fibre and colorectal cancer: a model for environment-gene interactions. Mol Nutr Food Res. 49(6):571–584.
  • Žáček P, Bukowski M, Mehus A, Johnson LAnn, Zeng H, Raatz S, Idso JP, Picklo M. 2019. Dietary saturated fatty acid type impacts obesity-induced metabolic dysfunction and plasma lipidomic signatures in mice. J Nutr Biochem. 64:32–44.
  • Zhou H, Urso CJ, Jadeja V. 2020. Saturated fatty acids in obesity-associated inflammation. J Inflamm Res. 13:1–14.
  • Zong G, Li Y, Wanders AJ, Alssema M, Zock PL, Willett WC, Hu FB, Sun Q. 2016. Intake of individual saturated fatty acids and risk of coronary heart disease in US men and women: two prospective longitudinal cohort studies. BMJ. 355i:5796.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.